LIPOPROTEIN FOR MULTIPLE ANALYTES— 510(k) K051619
Substantially EquivalentBayer Healthcare, LLC
FDA 510(k) clearance K051619 for LIPOPROTEIN FOR MULTIPLE ANALYTES, Substantially Equivalent on 2005-08-01. Applicant: Bayer Healthcare, LLC.
Clearance details
- Applicant
- Bayer Healthcare, LLC
- Product code
- Code JIX
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Abbreviated
- Location
- Tarrytown, NY, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.